Impact of non-randomised dropout on treatment switching adjustment in the relapsing-remitting multiple sclerosis CLARITY trial and the CLARITY extension study

Bell Gorrod, H. orcid.org/0000-0001-8054-8073, Latimer, N.R., Damian, D. et al. (3 more authors) (2019) Impact of non-randomised dropout on treatment switching adjustment in the relapsing-remitting multiple sclerosis CLARITY trial and the CLARITY extension study. Value in Health, 22 (7). pp. 772-776. ISSN 1098-3015

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 ISPOR-The Professional Society for Health Economics and Outcomes Research. This is an author produced version of a paper subsequently published in Value in Health. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: multiple sclerosis; rank preserving structural failure time model; Cladribine Tablets; disability progression
Dates:
  • Accepted: 2 December 2018
  • Published (online): 17 May 2019
  • Published: July 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 17 Jan 2019 11:43
Last Modified: 25 Jul 2019 15:16
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jval.2018.11.015

Download

Accepted Version


Embargoed until: 17 May 2020

Filename: Author accepted version - ViH CLARITY paper2.pdf

Licence: CC-BY-NC-ND 4.0

Request a copy

Share / Export

Statistics